155 related articles for article (PubMed ID: 38267664)
1. Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Imano H; Ogawa S
Osteoporos Int; 2024 May; 35(5):805-818. PubMed ID: 38267664
[TBL] [Abstract][Full Text] [Related]
2. Real-world effectiveness of anti-osteoporosis medications for the prevention of incident hip and clinical vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan.
Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Kamiya K; Ogawa S
Bone; 2023 Jan; 166():116605. PubMed ID: 36347433
[TBL] [Abstract][Full Text] [Related]
3. Delayed initiation of anti-osteoporosis medications increases subsequent hip and vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan.
Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Kamiya K; Ogawa S
Bone; 2022 Jul; 160():116396. PubMed ID: 35351673
[TBL] [Abstract][Full Text] [Related]
4. Guideline adherence by physicians for management of glucocorticoid-induced osteoporosis in Japan: a nationwide health insurance claims database study.
Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Kamiya K; Ogawa S
Osteoporos Int; 2022 May; 33(5):1097-1108. PubMed ID: 35022812
[TBL] [Abstract][Full Text] [Related]
5. Incidence of symptomatic vertebral fractures in women of childbearing age newly treated with high-dose glucocorticoid.
Sugiyama T; Suzuki S; Yoshida T; Suyama K; Tanaka T; Sueishi M; Tatsuno I
Gend Med; 2010 Jun; 7(3):218-29. PubMed ID: 20638627
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids Are Associated with an Increased Risk for Vertebral Fracture in Patients with Rheumatoid Arthritis.
Kim D; Cho SK; Park B; Jang EJ; Bae SC; Sung YK
J Rheumatol; 2018 May; 45(5):612-620. PubMed ID: 29545455
[TBL] [Abstract][Full Text] [Related]
7. Incidence of symptomatic vertebral fracture with high-dose glucocorticoid treatment in the Chiba-Shimoshizu Rheumatic Cohort between 1986 and 2006.
Sugiyama T; Tatsuno I; Suzuki S; Yoshida T; Tanaka T; Sueishi M; Saito Y
Endocr J; 2009; 56(4):591-9. PubMed ID: 19352047
[TBL] [Abstract][Full Text] [Related]
8. Fracture risk with intermittent high-dose oral glucocorticoid therapy.
De Vries F; Bracke M; Leufkens HG; Lammers JW; Cooper C; Van Staa TP
Arthritis Rheum; 2007 Jan; 56(1):208-14. PubMed ID: 17195223
[TBL] [Abstract][Full Text] [Related]
9. Incidence of fractures among patients receiving medications for type 2 diabetes or chronic obstructive pulmonary disease and glucocorticoid users according to the National Claims Database in Japan.
Fujiwara S; Ishii S; Hamasaki T; Okimoto N
Arch Osteoporos; 2021 Jun; 16(1):106. PubMed ID: 34191131
[TBL] [Abstract][Full Text] [Related]
10. Effects of Systemic Glucocorticoid Use on Fracture Risk: A Population-Based Study.
Koh JW; Kim J; Cho H; Ha YC; Kim TY; Lee YK; Kim HY; Jang S
Endocrinol Metab (Seoul); 2020 Sep; 35(3):562-570. PubMed ID: 32981298
[TBL] [Abstract][Full Text] [Related]
11. Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study.
Amiche MA; Abtahi S; Driessen JHM; Vestergaard P; de Vries F; Cadarette SM; Burden AM
Arch Osteoporos; 2018 Mar; 13(1):30. PubMed ID: 29552730
[TBL] [Abstract][Full Text] [Related]
12. Hip and vertebral fracture risk after initiating antidiabetic drugs in Japanese elderly: a nationwide study.
Tamaki J; Ogawa S; Fujimori K; Ishii S; Nakatoh S; Okimoto N; Kamiya K; Iki M
J Bone Miner Metab; 2023 Jan; 41(1):29-40. PubMed ID: 36517653
[TBL] [Abstract][Full Text] [Related]
13. Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip and vertebral fracture: analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
Nakatoh S; Fujimori K; Ishii S; Tamaki J; Okimoto N; Ogawa S; Iki M
Arch Osteoporos; 2021 Sep; 16(1):130. PubMed ID: 34510296
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of risk factors of vertebral fracture in Japanese female patients with glucocorticoid-induced osteoporosis.
Mori Y; Izumiyama T; Baba K; Mori N; Fujii H; Ishii T; Itoi E
J Orthop Surg Res; 2020 Jul; 15(1):290. PubMed ID: 32727595
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
Lin SM; Yang SH; Liang CC; Huang HK
Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
[TBL] [Abstract][Full Text] [Related]
16. Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database.
Adami G; Gatti D; Rossini M; Giollo A; Gatti M; Bertoldo F; Bertoldo E; Mudano AS; Saag KG; Viapiana O; Fassio A
Bone; 2024 Feb; 179():116958. PubMed ID: 37949390
[TBL] [Abstract][Full Text] [Related]
17. Age, initial dose and dose increase are independent risk factors for symptomatic vertebral fractures in glucocorticoid-treated male patients.
Sugiyama T; Suzuki S; Yoshida T; Mayama T; Hashimoto N; Suyama K; Tanaka T; Sueishi M; Tatsuno I
Intern Med; 2011; 50(8):817-24. PubMed ID: 21498928
[TBL] [Abstract][Full Text] [Related]
18. Effect of benign prostatic hyperplasia on the development of spine, hip, and wrist fractures.
Yang SC; Chiu YC; Liu PH; Hsieh TJ; Kao YH; Tu YK
Osteoporos Int; 2019 May; 30(5):1043-1049. PubMed ID: 30706096
[TBL] [Abstract][Full Text] [Related]
19. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
Van Staa TP; Laan RF; Barton IP; Cohen S; Reid DM; Cooper C
Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287
[TBL] [Abstract][Full Text] [Related]
20. Non-hip and non-vertebral fractures: the neglected fracture sites.
Holloway KL; Henry MJ; Brennan-Olsen SL; Bucki-Smith G; Nicholson GC; Korn S; Sanders KM; Pasco JA; Kotowicz MA
Osteoporos Int; 2016 Mar; 27(3):905-913. PubMed ID: 26438309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
